McMillan SJ - Search Results

1

Prolonged allergen challenge in mice leads to persistent airway remodelling.

McMillan SJ, Lloyd CM. McMillan SJ, et al. Clin Exp Allergy. 2004 Mar;34(3):497-507. doi: 10.1111/j.1365-2222.2004.01895.x. Clin Exp Allergy. 2004. PMID: 15005746 Free PMC article.

2

Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling.

McMillan SJ, Xanthou G, Lloyd CM. McMillan SJ, et al. Clin Exp Allergy. 2005 Mar;35(3):388-96. doi: 10.1111/j.1365-2222.02193.x. Clin Exp Allergy. 2005. PMID: 15784120 Free PMC article.

3

The absence of interleukin 9 does not affect the development of allergen-induced pulmonary inflammation nor airway hyperreactivity.

McMillan SJ, Bishop B, Townsend MJ, McKenzie AN, Lloyd CM. McMillan SJ, et al. J Exp Med. 2002 Jan 7;195(1):51-7. doi: 10.1084/jem.20011732. J Exp Med. 2002. PMID: 11781365 Free PMC article.

4

Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.

McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, Senior RM, Nourshargh S, Lloyd CM. McMillan SJ, et al. J Immunol. 2004 Feb 15;172(4):2586-94. doi: 10.4049/jimmunol.172.4.2586. J Immunol. 2004. PMID: 14764732

5

Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway.

McMillan SJ, Xanthou G, Lloyd CM. McMillan SJ, et al. J Immunol. 2005 May 1;174(9):5774-80. doi: 10.4049/jimmunol.174.9.5774. J Immunol. 2005. PMID: 15843580

6

Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo.

Kearley J, McMillan SJ, Lloyd CM. Kearley J, et al. Among authors: mcmillan sj. J Exp Med. 2007 Jun 11;204(6):1289-94. doi: 10.1084/jem.20062093. Epub 2007 May 21. J Exp Med. 2007. PMID: 17517968 Free PMC article.

7

A critical role for eosinophils in allergic airways remodeling.

Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C. Humbles AA, et al. Among authors: mcmillan sj. Science. 2004 Sep 17;305(5691):1776-9. doi: 10.1126/science.1100283. Science. 2004. PMID: 15375268

8

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.

Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ, Grönlund H, van Hage M, Reynolds CJ, Boyton RJ, Cobbold SP, Kay AB, Altmann DM, Lloyd CM, Larché M. Campbell JD, et al. Among authors: mcmillan sj. J Exp Med. 2009 Jul 6;206(7):1535-47. doi: 10.1084/jem.20082901. Epub 2009 Jun 15. J Exp Med. 2009. PMID: 19528258 Free PMC article.

9

Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model.

McMillan SJ, Richards HE, Crocker PR. McMillan SJ, et al. Immunol Lett. 2014 Jul;160(1):11-16. doi: 10.1016/j.imlet.2014.03.008. Epub 2014 Mar 31. Immunol Lett. 2014. PMID: 24698729 Free PMC article.

10

Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung.

McMillan SJ, Sharma RS, Richards HE, Hegde V, Crocker PR. McMillan SJ, et al. J Biol Chem. 2014 Jul 18;289(29):20370-6. doi: 10.1074/jbc.M114.574624. Epub 2014 Jun 3. J Biol Chem. 2014. PMID: 24895121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page